235 related articles for article (PubMed ID: 30497453)
1. In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
Xiao X; Jiang L; Lan W; Jiang Y; Wang Z
BMC Vet Res; 2018 Nov; 14(1):374. PubMed ID: 30497453
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling.
Liu X; Yang Q; Fan Y; Du Y; Lei L; Wang D; Liu Y
BMC Vet Res; 2021 Jun; 17(1):212. PubMed ID: 34107961
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens.
Xiao X; Sun J; Chen Y; Zou M; Zhao DH; Liu YH
Vet J; 2015 Apr; 204(1):54-9. PubMed ID: 25744809
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
Sang K; Hao H; Huang L; Wang X; Yuan Z
Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
[TBL] [Abstract][Full Text] [Related]
5. Enrofloxacin against Escherichia coli in turkeys: which treatment scheme is effective?
Cagnardi P; Ferraresi C; Lucatello L; Meucci V; Intorre L; Grilli G; Piccirillo A; Giacomelli M; Montesissa C
Poult Sci; 2014 Jul; 93(7):1667-74. PubMed ID: 24864295
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks.
Yu Y; Zhou YF; Sun J; Shi W; Liao XP; Liu YH
BMC Vet Res; 2017 Feb; 13(1):47. PubMed ID: 28183350
[TBL] [Abstract][Full Text] [Related]
7. Approved medication of water with enrofloxacin to treat turkey colibacillosis: assessment of efficacy using a PK/PD approach.
Russo E; Lucatello L; Giovanardi D; Cagnardi P; Ortali G; Di Leva V; Montesissa C
Vet Microbiol; 2012 Dec; 161(1-2):206-12. PubMed ID: 22884281
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic integration of enrofloxacin against
Kang J; Hossain MA; Park HC; Kim Y; Lee KJ; Park SW
J Vet Sci; 2019 Mar; 20(2):e15. PubMed ID: 30944537
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Vet Res Commun; 2006 Oct; 30(7):775-89. PubMed ID: 17004040
[TBL] [Abstract][Full Text] [Related]
10. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.
Xiao X; Chen X; Yan K; Jiang L; Li R; Liu Y; Wang M; Wang Z
J Vet Pharmacol Ther; 2022 Jan; 45(1):83-91. PubMed ID: 34469000
[TBL] [Abstract][Full Text] [Related]
11. The effect of a commercial competitive exclusion product on the selection of enrofloxacin resistance in commensal E. coli in broilers.
Chantziaras I; Smet A; Filippitzi ME; Damiaans B; Haesebrouck F; Boyen F; Dewulf J
Avian Pathol; 2018 Oct; 47(5):443-454. PubMed ID: 29874925
[TBL] [Abstract][Full Text] [Related]
12. Interaction between Enrofloxacin and Three Essential Oils (Cinnamon Bark, Clove Bud and Lavender Flower)-A Study on Multidrug-Resistant
Zych S; Adaszyńska-Skwirzyńska M; Szewczuk MA; Szczerbińska D
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791259
[TBL] [Abstract][Full Text] [Related]
13. Effect of an organic acids based feed additive and enrofloxacin on the prevalence of antibiotic-resistant E. coli in cecum of broilers.
Roth N; Mayrhofer S; Gierus M; Weingut C; Schwarz C; Doupovec B; Berrios R; Domig KJ
Poult Sci; 2017 Sep; 96(11):4053-4060. PubMed ID: 29050428
[TBL] [Abstract][Full Text] [Related]
14. In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals.
Cengiz M; Sahinturk P; Sonal S; Buyukcangaz E; Sen A; Arslan E
Vet Rec; 2013 May; 172(18):474. PubMed ID: 23605176
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro activities and pharmacokinetics/pharmacodynamics estimations of veterinary fluoroquinolones against avian pathogenic Escherichia coli isolates.
Ozawa M; Baba K; Shimizu Y; Asai T
Microb Drug Resist; 2010 Dec; 16(4):327-32. PubMed ID: 20624095
[TBL] [Abstract][Full Text] [Related]
16. Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli.
Khan DD; Lagerbäck P; Malmberg C; Kristoffersson AN; Wistrand-Yuen E; Sha C; Cars O; Andersson DI; Hughes D; Nielsen EI; Friberg LE
Int J Antimicrob Agents; 2018 Mar; 51(3):399-406. PubMed ID: 29127049
[TBL] [Abstract][Full Text] [Related]
17.
Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilis.
Hu J; Zhang J; Chen Y; Liang W; Wu S
Clin Ther; 2017 Apr; 39(4):828-836. PubMed ID: 28363695
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens.
Bonassa KPD; Miragliotta MY; Simas RC; Eberlin MN; Anadón A; Moreno RA; Reyes FGR
Front Vet Sci; 2020; 7():606872. PubMed ID: 33490134
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/pharmacodynamic relationship of enrofloxacin against Aeromonas hydrophila in crucian carp (Carassius auratus gibelio).
Shan Q; Wang J; Wang J; Ma L; Yang F; Yin Y; Huang R; Liu S; Li L; Zheng G
J Vet Pharmacol Ther; 2018 Dec; 41(6):887-893. PubMed ID: 29943470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
